WHWK
NASDAQ · Biotechnology
Whitehawk Therapeutics Inc
$4.58
+0.17 (+3.85%)
Open$4.41
Previous Close$4.41
Day High$4.76
Day Low$4.31
52W High$5.50
52W Low$1.57
Volume—
Avg Volume393.0K
Market Cap221.05M
P/E Ratio—
EPS$-3.59
SectorBiotechnology
Analyst Ratings
Buy
12 analysts
Price Target
+277.9% upside
Current
$4.58
$4.58
Target
$17.31
$17.31
$14.24
$17.31 avg
$28.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 7.58M | 9.76M | 8.91M |
| Net Income | -21,849,902 | -25,302,253 | 2.41M |
| Profit Margin | -288.3% | -273.9% | 27.1% |
| EBITDA | -28,701,440 | -35,082,820 | 4.31M |
| Free Cash Flow | — | — | 1.46M |
| Rev Growth | -22.3% | -22.3% | +22.0% |
| Debt/Equity | — | — | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |